Publication | Open Access
Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
39
Citations
32
References
2022
Year
Decreasing preference for high-caloric, high-fat foods is a powerful action of GLP-1R and dual GIPR/GLP-1R agonist therapeutics, which may contribute to the weight loss success of these drugs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1